Vimarsana
Biggest News Aggregation in the World

Surgical Resection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Surgical Resection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Surgical Resection Today - Breaking & Trending Today

Procedural sedation and analgesia versus general anesthesia for hysteroscopic myomectomy (PROSECCO trial): A multicenter randomized controlled trial - Vimarsana News

Procedural sedation and analgesia versus general anesthesia for hysteroscopic myomectomy (PROSECCO trial): A multicenter randomized controlled trial

Julia van der Meulen and co-workers compare procedural sedation and analgesia versus general anesthesia in women undergoing hysteroscopic myomectomy for fibroids.

Source: plos.org
Reviewing Best Practices in the Surgical Management of Breast Cancer: Opportunities for Stage IV Disease - Vimarsana News

Reviewing Best Practices in the Surgical Management of Breast Cancer: Opportunities for Stage IV Disease

In this fourth episode of OncChats: Reviewing Best Practices in the Surgical Management of Breast Cancer, Gladys Giron, MD, FACS, and Cristina Lopez-Peñalver, MD, discuss how to appropriately manage patients with stage IV breast cancer and outline when surgical approaches may be appropriate for this population.

Timing Fertility Preservation in Patients With Breast Cancer Undergoing Surgery - Vimarsana News

Timing Fertility Preservation in Patients With Breast Cancer Undergoing Surgery

Expert oncologists Matteo Lambertini, MD, PhD, and Virginia Kaklamani, MD, DSc, review fertility preservation strategies in the context of patients with breast cancer undergoing surgery.

Key Decisionmaking Factors in Resectable Non–Small Cell Lung Cancer - Vimarsana News

Key Decisionmaking Factors in Resectable Non–Small Cell Lung Cancer

Expert oncologists reflect on key factors that aid in the selection of therapy for patients diagnosed with resectable non–small cell lung cancer (NSCLC).

CSCC: Translating Cemiplimab Data Into Practice - Vimarsana News

CSCC: Translating Cemiplimab Data Into Practice

Following their review of recent clinical data, expert panelists consider how neoadjuvant cemiplimab will fit into the real-world treatment paradigm of resectable CSCC, including the possibility of delaying or avoiding surgery in patients who have an adequate response to cemiplimab.